Long-term survival of immunocompetent rats with intraperitoneal colon carcinoma tumors using herpes simplex thymidine kinase/ganciclovir and IL-2 treatments

Gene Therapy
J L CollM C Favrot

Abstract

We evaluated the gain in long-term survival of BDIX rats bearing DHDProB colon cancer developed in the peritoneal cavity after in vivo therapy with the tk gene and GCV. The sensitivity and the bystander effect of DHDProB cells stably transduced with the tk gene evaluated in vitro were low, as one tk+ cell killed two tk- cells. This correlated with the low ability of a fluorescent dye to diffuse through gap junctions. In vivo, more than 75% of tk-transduced cells were required and at least 100 mg/kg/day of GCV had to be injected no later than day 5 after tumor implantation to obtain a curative effect. A partial protection of the cured animals against rechallenge with the parental cells was also observed. Based on these results, a protocol of in vivo gene therapy was designed in which the tk/GCV treatment was combined with IL-2 gene expression. When the tk- and IL-2 encoding plasmids were injected twice i.p. with DOTAP and the animals treated with GCV, three of five rats were cured. This antitumoral activity resulted from the combined toxic effects of DNA/DOTAP and tk/GCV plus a potential immune response mediated by IL-2.

Citations

Mar 10, 2001·Journal of Cellular Physiology·O Greco, G U Dachs
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Ajay GautamCharles L Densmore
Jul 5, 2005·Expert Opinion on Investigational Drugs·M J PerryA G Dalgleish
Dec 6, 2005·Hematology/oncology Clinics of North America·Daniel H Sterman
May 4, 2015·The Journal of Surgical Research·Barur R RajeshkumarGiles F Whalen
Oct 29, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Tomoaki GotoYukitaka Ushio
Sep 27, 2018·Cancer Biology & Therapy·Jianyong XiaoBiaoyan Du
Jul 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Holger PalmedoHans-Jurgen Biersack

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.